Zacks Research Issues Optimistic Estimate for CORT Earnings
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Stock analysts at Zacks Research raised their Q2 2026 EPS estimates for shares of Corcept Therapeutics in a research note issued to investors on Wednesday, April 2nd. Zacks Research analyst K. Das now anticipates that the biotechnology company will earn $0.68 per share for the quarter, up […]
Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) – Stock analysts at Zacks Research raised their Q2 2026 EPS estimates for shares of Corcept Therapeutics in a research note issued to investors on Wednesday, April 2nd. Zacks Research analyst K. Das now anticipates that the biotechnology company will earn $0.68 per share for the quarter, up […]
